Showing results (371-380 of 669) with videos related to
Sort By:
Pageof 67
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Bert Gold, Tomas Kirchhoff, Stefan Stefanov, et al.Cancer|October 28, 2015
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinomaA Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, et al.NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.Public Health Genomics|October 24, 2024
"Should I Let Them Know I Have This?": Multifaceted Genetic Discrimination and Limited Awareness of Legal Protections among Individuals with Hereditary Cancer SyndromesRidhi Gopalakrishnan, Jordan Sam, Carly Butkowsky, et al.European Journal of Human Genetics : EJHG|October 11, 2023
"I just wanted more": Hereditary cancer syndromes patients' perspectives on the utility of circulating tumour DNA testing for cancer screeningElla Adi-Wauran, Marc Clausen, Salma Shickh, et al.NPJ Breast Cancer|October 12, 2021
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombinationJeremy Setton, Pier Selenica, Semanti Mukherjee, et al.Nature Medicine|July 26, 2011
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaTimothy Best, Dalin Li, Andrew D Skol, et al.Cancer Research|April 1, 2008
The signatures of autozygosity among patients with colorectal cancerManny D Bacolod, Gunter S Schemmann, Shuang Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate CancerKonrad H Stopsack, Joseph Vijai, Michael Conry, et al.JAMA Oncology|November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAKasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.Pageof 67